Non-human primate CD4 polypeptides, human CD4 molecules capable of glycosylation, fragments thereof, fusion proteins thereof, genetic sequences thereof, and the use thereof
US5420264A · kind A · utility
8Cited by
4References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 17, 1992 |
| Grant date | May 30, 1995 |
| Priority date | — |
| Expiry date | Jul 17, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/33
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, in general, to substantially pure polynucleotide molecules specifying chimpanzee or rhesus monkey CD4, and fragments thereof and Gp120 binding molecules related to human CD4. The present invention further relates to polynucleotide molecules specifying CD4 fusion proteins and host cells containing the polynucleotide molecules.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.